Wei Wang

Wei Wang

Auto-generated profile, based on publicly available information

Wei Wang

Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 200030 Shanghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2025 in Neuropharmacology
Verified
Journal Article
Closed access
WWWei Wang
Wei Wang
YDYingzhuo Ding
Yingzhuo Ding
CYChunxia Yu
Chunxia Yu
QCQingqing Chi
Qingqing Chi
XFXia Fu
Xia Fu
LMLe Ma
Le Ma

21 May 2026 in ALPHA PSYCHIATRY
Verified
Journal Article
Open access
PDF file
WWWeidi Wang
Weidi Wang
WWWei Wang
Wei Wang
XWXuechen Wang
Xuechen Wang
ZLZhe Liu
Zhe Liu
YFYu Fang
Yu Fang
DPDaihui Peng
Daihui Peng
Histone modifications have emerged as critical epigenetic regulators in the development and progression of mental disorders. This review synthesizes recent advances in the field, highlighting both canonical modifications, such as methylation, acetylation, and phosphorylation, as well as novel discoveries that link neurotransmitter signaling to chromatin regulation. In particular, neurotransmitter-mediated histone modifications, including serotonylation, dopaminylation, and histaminylation, represent a compelling new paradigm by which neuronal activity and environmental stimuli can induce lasting changes in gene expression. Aberrant histone modifications have been implicated in the risk, symptomatology, and treatment response of psychiatric conditions such as depression, bipolar disorder, and schizophrenia. Furthermore, therapeutic strategies that target histone-modifying enzymes, most notably histone deacetylase inhibitors, are being actively explored for their potential to restore epigenetic balance and improve clinical outcomes. A deeper understanding of the mechanistic diversity and disease specificity of histone modifications will be crucial for the development of precision epigenetic therapies in psychiatry.